Prosta Fink Forte^(r) in the Therapy of Benign Prostatic Hyperplasia. Multicentric Surveillance Study in 2,245 Patients Objective and Design:Therapeutic use and safety of a pumpkin seed extract were tested in a multicentric clinical trial. Patients and Methods:2,245 patients suffering from benign prostate hyperplasia (stage I to II according to Alken) received for 12 weeks 1–2 capsules Prosta Fink Forte per day. Urinary symptoms were recorded by the International Prostate Symptom Score according to the American Urological Association (I-PSS), the influence on quality of life has been recorded by a quality of life questionnaire (LQ Index). Results:The I-PSS decreased by 41.4%, life quality improved by 46.1% during therapy. More than 96% of the patients reported no undesired side effects under the treatment with Prosta Fink Forte. Conclusion:Prosta Fink Forte facilitates an efficient improvement of BPH symptoms, especially in early stages.